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http://respiratory-research.com/content/13/1/73RESEARCH Open AccessNitric oxide-induced eosinophil apoptosis is
dependent on mitochondrial permeability
transition (mPT), JNK and oxidative stress:
apoptosis is preceded but not mediated by early
mPT-dependent JNK activation
Pinja Ilmarinen-Salo1*, Eeva Moilanen1, Vuokko L Kinnula2 and Hannu Kankaanranta1,3Abstract
Background: Eosinophils are critically involved in the pathogenesis of asthma. Nitric oxide (NO) is produced in high
amounts in asthmatic lungs and has an important role as a regulator of lung inflammation. NO was previously shown to
induce eosinophil apoptosis mediated via c-jun N-terminal kinase (JNK) and caspases. Our aim was to clarify the cascade
of events leading to NO-induced apoptosis in granulocyte macrophage-colony stimulating factor (GM-CSF)-treated
human eosinophils concentrating on the role of mitochondria, reactive oxygen species (ROS) and JNK.
Methods: Apoptosis was determined by flow cytometric analysis of relative DNA content, by Annexin-V labelling and/or
morphological analysis. Immunoblotting was used to study phospho-JNK (pJNK) expression. Mitochondrial membrane
potential was assessed by JC-1-staining and mitochondrial permeability transition (mPT) by loading cells with calcein
acetoxymethyl ester (AM) and CoCl2 after which flow cytometric analysis was conducted. Statistical significance was
calculated by repeated measures analysis of variance (ANOVA) or paired t-test.
Results: NO-donor S-nitroso-N-acetyl-D,L-penicillamine (SNAP) induced late apoptosis in GM-CSF-treated eosinophils.
SNAP-induced apoptosis was suppressed by inhibitor of mPT bongkrekic acid (BA), inhibitor of JNK SP600125 and
superoxide dismutase-mimetic AEOL 10150. Treatment with SNAP led to late loss of mitochondrial membrane potential.
Additionally, we found that SNAP induces early partial mPT (1 h) that was followed by a strong increase in pJNK levels
(2 h). Both events were prevented by BA. However, these events were not related to apoptosis because SNAP-induced
apoptosis was prevented as efficiently when BA was added 16 h after SNAP. In addition to the early and strong rise,
pJNK levels were less prominently increased at 20–30 h.
Conclusions: Here we demonstrated that NO-induced eosinophil apoptosis is mediated via ROS, JNK and late mPT.
Additionally, our results suggest that NO induces early transient mPT (flickerings) that leads to JNK activation but is not
significant for apoptosis. Thereby, we showed some interesting early events in NO-stimulated eosinophils that may take
place even if the threshold for irreversible mPT and apoptosis is not crossed. This study also revealed a previously
unknown physiological function for transient mPT by showing that it may function as initiator of non-apoptotic JNK
signalling.
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Eosinophils play a crucial role in the pathogenesis of
asthma. By releasing toxic granule proteins, lipid media-
tors and other proinflammatory components, eosino-
phils contribute especially to exacerbations of asthma
[1]. Additionally, eosinophils have gained increasing at-
tention as antigen-presenting cells and as important reg-
ulators of T-helper (Th) 2 cytokine production and
airway remodelling [2,3]. Eosinophils typically exist in
low numbers in human peripheral blood complicating
studies on their functions. They undergo spontaneous
apoptosis in few days in the absence of any survival-
prolonging cytokines. Blood eosinophils obtained from
patients with asthma show delayed apoptosis when com-
pared to eosinophils from healthy controls [4] and ele-
vated levels of eosinophil survival-prolonging cytokines
interleukin (IL)-5 and granulocyte macrophage-colony
stimulating factor (GM-CSF) have been found from the
bronchoalveolar lavage fluid of asthmatics [5]. GM-CSF
has been demonstrated as the main eosinophil-survival
prolonging cytokine in asthmatic airways [6]. Apoptosis
is an efficient way to discard eosinophils from the air-
ways by avoiding inflammation. It is characterized by cell
shrinkage, chromatin condensation, nuclear coalescence,
DNA fragmentation, mitochondrial changes and transfer
of phosphatidyl serine residues from the inner to the
outer leaflet of the cell membrane.
Nitric oxide (NO) is a gaseous molecule possessing both
physiological and pathophysiological role in human tissues
[7]. During inflammation, inducible nitric oxide synthase
(iNOS) is rapidly activated by bacterial endotoxin and in-
flammatory cytokines IL-1, tumor necrosis factor (TNF)-
α and IFN-γ resulting in high production of NO. In
inflamed airways, NO is produced by iNOS in alveolar
macrophages and bronchial epithelial cells. Patients with
asthma show elevated levels of NO in the exhaled air,
which correlates to clinical symptoms of asthma, sputum
eosinophilia and eosinophil activation markers [8,9]. How-
ever, in a rat-model of asthma NO-releasing glucocortic-
oid was shown to be more potent than glucocorticoid
alone. In addition, NO-releasing compound diethylene-
triamine (DETA)-NONOate was shown to be as potent as
a glucocorticoid in inhibiting eosinophilic inflammation
[10]. NO may have both pro- and anti-inflammatory prop-
erties in asthmatic inflammation.
Interestingly, we have previously shown that exogenous
NO induces human eosinophil apoptosis in vitro in the ab-
sence and presence of IL-5 and GM-CSF, which may act as
a counter regulatory mechanism to limit eosinophilia in
inflamed lungs [11,12]. Apoptotic rate of sputum eosino-
phils was found to positively correlate with exhaled NO in
children [13] indicating that induction of eosinophil apop-
tosis by NO may have clinical relevance. NO was shown to
possess its pro-apoptotic effect via c-Jun-N-terminal kinase(JNK) [11] and caspases 6 and 3 [12]. In previous studies
with other cell types and cell-free systems treatment with
NO has been found to lead to formation of reactive oxygen
species (ROS), stimulation of mitochondrial permeability
transition (mPT) and disruption of mitochondrial function
[14,15]. Mitochondrial permeability transition pore is a Ca2+-
and voltage-dependent channel in mitochondrial inner
membrane for molecules up to 1.5 kDa. Ca2+-overload
induces mPT pore to open resulting in equilibration of
small molecules across the inner membrane, loss of mito-
chondrial membrane potential (ΔΨm), mitochondrial
swelling and finally rupture of the outer mitochondrial
membrane which releases cytochrome c and other pro-
apoptotic factors to cytosol to initiate apoptosis [16]. Only
scarce information exists of the function of mPT in eosi-
nophils [17]. JNK is a stress-regulated kinase that has been
previously shown to mediate apoptosis by increasing tran-
scription of several pro-apoptotic molecules and by phos-
phorylating B-cell lymphoma (Bcl) 2 family members
thereby participating in mitochondrial apoptotic pathway
[18]. This study was conducted to find out the cascade
of events and signalling mechanisms leading to NO-
induced eosinophil apoptosis in the presence of survival-
prolonging cytokine GM-CSF, especially concentrating on
the role of ROS, JNK and mitochondria.
Methods
Materials
AEOL 10150 was a kind gift from Prof. James Crapo
(University of Colorado, Denver, USA). Materials were
purchased as previously described [12] or as follows:
SP600125, negative control for SP600125, JNK inhibitor
VIII, bongkrekic acid, apocynin (Merck, Darmstadt,
Germany), diphenyleneiodonium chloride (DPI) (Sigma-
Aldrich Co., St. Louis, MO, USA), JC-1 mitochondrial
membrane potential detection kit (Biotium Inc., Hayward,
CA, USA), MitoProbe transition pore assay kit (Molecular
Probes Inc., Eugene, OR, USA), phospho-JNK (pJNK) anti-
body (Thr183/Tyr185) (Cell Signaling Technology Inc.,
Danvers, MA, USA), JNK antibody (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA).
Human eosinophil purification and culture
The blood samples (100 ml) were taken from healthy, aller-
gic or asthmatic individuals. All donors gave written
informed consent to a study protocol approved by the eth-
ical committee of Tampere University Hospital. Eosinophils
were isolated to >99% purity and cultured under sterile
conditions as previously described [12].
Apoptosis assays and western blotting
Relative DNA fragmentation assay of propidium iodide
(PI)-stained cells, morphological analysis, Annexin-V
Table 1 Effect of SNAP on GM-CSF-induced eosinophil
survival as previously described [12]
Apoptotic cells (%)
Untreated 60.8 ± 4.1
GM-CSF 10 pM 11.1 ± 1.6
+SNAP 10 μM 10.5 ± 1.8
+SNAP 100 μM 28.4 ± 10.9
+SNAP 1000 μM 44.6 ± 8.6 **
GM-CSF 10 pM 9.3 ± 1.0
+Penicillamine 100 μM 8.6 ± 1.2
+Penicillamine 1000 μM 8.6 ± 2.1
Apoptosis was determined after 40 h of incubation by DNA fragmentation
assay. Shown are mean ± SEM, n = 7. ** indicates p < 0.01 as compared with
GM-CSF-treated cells.
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performed as previously described [12].
Measurement of mitochondrial membrane potential
Mitochondrial membrane potential (ΔΨm) was deter-
mined by staining eosinophils with cationic mitochon-
drial dye JC-1 followed by flow cytometric analysis [19].
In cells with intact ΔΨm JC-1 accumulates into mito-
chondrial matrix. When the critical concentration is
achieved, JC-1 aggregates releasing red fluorescence. In
cells with collapsed ΔΨm JC-1 remains in a monomeric
form in the cytoplasm emitting green fluorescence. Cells
(2.5-5 x 105) were stained for 15 min with JC-1 at 37°C,
washed twice in medium and re-suspended in PBS, after
which flow cytometric analysis was conducted. K+ iono-
phore valinomycin is a drug able to collapse ΔΨm and
was used as a positive control [19]. The gates defining
cells with intact and lost ΔΨm were based on cells trea-
ted with GM-CSF (10 pM) and valinomycin (1 μM), re-
spectively, in each experiment individually.
Determination of mitochondrial permeability transition
Mitochondrial permeability transition was determined
by MitoProbe transition pore assay kit (Molecular
Probes Inc., Eugene, OR, USA), a technique based on
calcein acetoxymethyl ester (AM) and CoCl2 [20]. Cal-
cein AM is a non-fluorescent molecule which accumu-
lates into cytosol and mitochondria. Cleavage of calcein
AM by intracellular esterases liberates fluorescent cal-
cein dye that does not cross plasma or mitochondrial
membrane. In normal cells, addition of CoCl2 quenches
the fluorescence of cytosolic but not mitochondrial cal-
cein. In cells with mPT, CoCl2 enters also mitochondria
to quench the mitochondrial calcein fluorescence. Cal-
cein AM/CoCl2-method requires activity of intracellular
esterases that are functional only in vital cells restricting
use of this method. Cells (5 x 105) were labeled with 10
nM calcein AM, 400 μM CoCl2 and/or 0.5 μM ionomy-
cin for 15 min at 37°C. Cells were washed with HBSS,
resuspended in PBS and analyzed by flow cytometry.
Ionomycin, known to induce complete mPT, always pro-
duced minimal fluorescence of 2–4 mean fluorescence
intensity (MFI) in the presence or absence of GM-CSF,
penicillamine or SNAP indicative of complete mPT. Cal-
cein fluorescence is expressed as percentage of its initial
value ((mean of calcein fluorescence of cells treated with
calcein AM and CoCl2 / mean of calcein fluorescence of
cells treated with calcein AM) * 100). This data was fi-
nally normalized against control cells (cells treated with
GM-CSF and penicillamine).
Statistics
Results are shown as mean ± SEM. Statistical signifi-
cance was calculated by repeated measures analysis ofvariance with Dunnett’s post-test or by paired t-test by
using GraphPad InStat version 3.05 (GraphPad Software,
San Diego, CA, USA). Differences were considered sig-
nificant when p < 0.05.
Results
SNAP induces apoptosis in GM-CSF-treated eosinophils
NO-donor SNAP but not the negative control N-acetyl-
D,L-penicillamine induced apoptosis in GM-CSF-treated
eosinophils as previously described and as indicated in
Table 1 [12]. Time-course of SNAP-induced apoptosis
revealed late initiation of cell death. SNAP induced only
a minor increase in DNA fragmentation at 16 and 24 h
time-points and a significant increase was observed only
after 40 h of incubation (Figure 1).
SNAP-induced apoptosis is dependent on late mPT but
preceded by early partial mPT
Mitochondrial membrane permeabilization including
mPT and loss of ΔΨm are critical steps in mitochondrial
apoptotic pathway [16]. We used calcein AM/CoCl2-
method to assess whether SNAP induces mPT in GM-
CSF-treated eosinophils. We found that SNAP reduced
calcein fluorescence by 34.6 ± 7.7% when compared to
penicillamine-treated cells at 1 h indicating that mPT
occurs and CoCl2 enters mitochondria to quench calcein
fluorescence (Figures 2A-D). This effect was mostly prevented
by bongkrekic acid, an inhibitor of mPT (Figures 2A-D).
However, when compared to ionomycin-induced
complete mPT as indicated by total quench of calcein
fluorescence (data not shown), mPT raised by SNAP
was partial.
To determine whether mPT is important for apoptosis
in the presence or absence of SNAP and GM-CSF, we
treated the cells with bongkrekic acid. Indeed, bongk-
rekic acid significantly reversed the effect of SNAP on
DNA fragmentation (Figure 2E), cell morphology
(Figure 2F) and Annexin-V labeling (Figure 2G). Only a
Figure 1 SNAP induces late apoptosis in GM-CSF-treated
eosinophils. Eosinophils were incubated in the presence or absence
of 1 mM SNAP, 1 mM penicillamine and/or 10 pM GM-CSF for the
indicated times. Apoptosis was measured by DNA fragmentation
assay. *** indicates p < 0.001 as compared with cells treated with
GM-CSF and penicillamine at the corresponding time-point. Mean ±
SEM is shown from six independent experiments.
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by treatment with bongkrekic acid (Figures 2E-G). To
examine whether the early mPT at 1 h time-point is crit-
ical for SNAP-induced apoptosis, we added bongkrekic
acid to eosinophils at later, arbitrary time-point, 16 h
after SNAP and GM-CSF. Surprisingly, SNAP-induced
apoptosis was prevented even when bongkrekic acid was
added to the cells 16 h after SNAP and GM-CSF
(Figure 2H) indicating that early partial mPT is not sig-
nificant for apoptosis. Thus, the threshold for apoptosis-
inducing complete mPT is achieved 16–40 h after
addition of SNAP.
SNAP induces late loss of mitochondrial membrane
potential
Two forms of mPT have been previously identified. Sus-
tained opening of the mPT pore leads to loss of ΔΨm
resulting in cell death. However, transient or flickering
openings of the mPT pore may only lead to mitochon-
drial membrane depolarization spikes, but not to per-
manent loss of ΔΨm and cell death [21,22]. Next our
aim was to determine the effect of SNAP on ΔΨm at dif-
ferent time-points to get further evidence that only mPT
occurring at late stage results in loss of ΔΨm and is crit-
ical for apoptosis. As expected, we found that SNAP did
not significantly increase the proportion of cells with lost
ΔΨm after 20 h of incubation (Figure 3A). At 40 h time-
point, loss of ΔΨm occurred in most of SNAP-treated
but not penicillamine-treated cells (Figures 3A-C). Thisresult supports the conclusion that SNAP induces per-
manent mPT leading to loss of ΔΨm and apoptosis at
late stage.
JNK mediates SNAP-induced apoptosis but is also
induced by early non-apoptotic mPT
We have previously shown that SNAP-induced apoptosis
is dependent on JNK and demonstrated early activation
of JNK by SNAP [11]. To more carefully explore the pat-
tern of JNK activation we studied pJNK levels during
longer time-scale. SNAP induced a strong JNK phos-
phorylation at 2 h time-point and smaller increases in
pJNK levels at 1 h, 20 h and 30 h time-points
(Figure 4A). As expected, untreated eosinophils showed
stable pJNK levels (Figure 4A). To examine if early acti-
vation of JNK is a consequence of early mPT, we used
bongkrekic acid to inhibit mPT. Treatment with bongk-
rekic acid completely prevented SNAP-induced increase
in pJNK levels at 2 h time-point (Figure 4B).
In previous studies it has been demonstrated that
rapid, strong and transient JNK activation is a stress re-
sponse resulting in cell survival signalling while delayed
and sustained JNK activation is related to apoptosis
[23,24]. To clarify whether the early (2 h) and/or late
(20–30 h) JNK activation is important for SNAP-
induced eosinophil apoptosis, we used JNK inhibitor
SP600125 added before and/or 16 h after SNAP. We
found that if SP600125 was added only at 16 h time-
point it had no effect on SNAP-induced apoptosis
(Figure 4C). Surprisingly, SP600125 added only before
SNAP was not effective either (Figure 4C). Nevertheless,
a clear inhibition of SNAP-induced apoptosis was seen
when SP600125 was added at both of these time-points
(Figure 4C). A chemically different inhibitor of JNK,
JNK inhibitor VIII (1 μM), partly prevented SNAP-
induced eosinophil apoptosis when added once 30 min
before SNAP (P < 0.05, n = 7, data not shown). The
results suggest that the later JNK activation is involved
in mediating apoptosis but the later phase may begin
earlier than 16 h and persist at least up to 30 h after
addition of SNAP.
Activation of JNK has been previously shown to medi-
ate cell death by participating in the induction of mPT
and loss of ΔΨm [25,26]. We did not find, however, any
role for JNK in stimulating these mitochondrial changes
because inhibition of JNK by SP600125 or JNK inhibitor
VIII did not reverse SNAP-induced loss of ΔΨm at 40 h
time-point (p > 0.05, n = 4-5, data not shown).
Significant role of early ROS production in SNAP-induced
apoptosis
Cellular stress often results in increased production of
ROS such as superoxide (O2
-), hydroxyl radical (OH)
and hydrogen peroxide (H2O2) by mitochondrial
Figure 2 SNAP-induced apoptosis is dependent on late mPT but preceded by early partial mPT. Bongkrekic acid (62 μM) or solvent was
added either 2 h before (A-H) or 16 h (H) after 10 pM GM-CSF, 1 mM SNAP and/or 1 mM penicillamine. In A-D Eosinophils were incubated for
1 h after which mPT was determined by calcein AM/CoCl2-method as described in materials and methods. In A-C shown are representative
graphs from analysis of mPT and in the top right corner percentage of calcein fluorescence of its initial value describing the extent of mPT. In E-H
total incubation time of eosinophils was 40 h after which apoptosis was determined by DNA fragmentation assay (E, H), morphological analysis
(F) or Annexin-V FITC staining (G). Values are mean ± SEM from five to six independent experiments, * indicates p < 0.05 and ** p < 0.01 as
compared with the respective control.
Ilmarinen-Salo et al. Respiratory Research 2012, 13:73 Page 5 of 11
http://respiratory-research.com/content/13/1/73respiratory chain, NADPH oxidase or other enzymes
such as cyclooxygenase (COX). These radicals partici-
pate in the generation of several toxic metabolites. One
of the most toxic metabolites formed in the presence of
superoxide and nitric oxide is peroxynitrite, whichinduces DNA damage, lipid peroxidation and inhibits
several cytoplasmic and mitochondrial enzymes [27]. To
determine whether SNAP-induced apoptosis in the pres-
ence of GM-CSF is dependent on superoxide and/or
peroxynitrite formation, we used a small-molecule
Figure 3 SNAP induces late loss of ΔΨm. Eosinophils were incubated with solvent, SNAP (1 mM), penicillamine (1 mM) and/or GM-CSF (10 pM)
for indicated times (A) or for 40 hours (B-C) after which JC-1-staining and analysis of mitochondrial membrane potential by flow cytometer was
conducted as described in materials and methods. In A shown are mean ± SEM from five independent experiments. * indicates p < 0.05 and
** p < 0.01 when compared to cells treated with GM-CSF or GM-CSF and penicillamine, respectively. In B-C shown are representative graphs from
analysis of ΔΨm with percentages of cells with lost ΔΨm.
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the catalytic site of SOD [27]. AEOL partly prevented
the pro-apoptotic effect of SNAP but not spontaneous
apoptosis indicating that treatment with SNAP specific-
ally increases cellular ROS production (Figure 5A). When
AEOL was added 16 hours after SNAP and GM-CSF, the
treatment had no effect any more on SNAP-induced
apoptosis (Figure 5B) indicating importance of early
production of ROS. Inhibitors of NADPH oxidase,
DPI and apocynin, had no significant effect on SNAP-
induced apoptosis suggesting that NADPH oxidase is
not the source of superoxide (Figures 5C-D). As a
conclusion, early superoxide and/or peroxynitrite pro-
duction is an important step in SNAP-induced apop-
tosis but superoxide does not originate from NADPH
oxidase.
Discussion
Nitric oxide is produced in high amounts in asthmatic
lungs and has an important role as a regulator of lung
inflammation. In this study, we found that NO prevents
the survival-prolonging effect of GM-CSF in eosinophils
by inducing apoptosis consistently with our previous
reports [11,12]. We focused here to the cascade of
events leading to NO-induced eosinophil apoptosis par-
ticularly concentrating on the role of mitochondria, ROS
and JNK. We showed that NO-induced eosinophil apop-
tosis is dependent on early ROS production, JNK and
late mPT. In addition, we found that NO induced an
early partial mPT and mPT-dependent JNK activation
but those events seemed not mediate NO-induced apop-
tosis detected at later time points.
Mitochondrial permeability transition pore is a chan-
nel in the inner mitochondrial membrane that is com-
posed of several proteins in a complex manner. Themolecular structure of the channel has not yet been
resolved despite of numerous attempts and it has been
postulated that the structure may vary depending on the
cell type and/or the trigger. Inhibitor of mPT, bongk-
rekic acid, acts as a ligand to adenine nucleotide translo-
cator (ANT), which is either a component or an
important regulator of mPT [28,29]. ANT has been
shown to act as a critical target in mitochondrial mem-
brane permeabilization induced by NO and peroxynitrite
[30], giving ground for usage of bongkrekic acid as an
inhibitor of mPT in this study. Here, we also showed
that bongkrekic acid inhibits mPT in eosinophils.
Our results demonstrate that NO has a marked and
varied effect on mPT at long time-scale. We found that
NO induces partial mPT at 1 h in eosinophils that does
not lead to early permanent loss of ΔΨm. This strongly
suggests that early NO-induced mPT is transient or
flickering. Previously, flickering mPT has been demon-
strated in healthy intact cells [21,31] and it has been pos-
tulated to act as a fast calcium release mechanism [32,33]
participating thereby in diverse range of Ca2+ -mediated
cellular activities. Flickering mPT may also be involved
in cell protection during minor stress [34] or it may act
as an early signal for oxidative stress-induced apoptosis
[31]. In accordance with our results, NO was shown to
induce and modulate mPT in a reversible manner in
isolated mitochondria [35]. We found that the early
mPT is not significant for initiation of NO-induced
apoptosis because addition of mPT inhibitor bongk-
rekic acid at 16 h after SNAP and GM-CSF still effi-
ciently prevented NO-induced apoptosis. This seems to
be in contrast to the findings of Ma et al. [31] who
showed that early flickering mPT and associated super-
oxide flashes induced by selenite are early signals of
apoptosis. They showed that manipulation of selenite-
Figure 4 JNK mediates SNAP-induced apoptosis but is also
strongly induced by early non-apoptotic mPT. In A eosinophils
were incubated in the presence or absence of 1 mM SNAP, 1 mM
penicillamine and/or 10 pM GM-CSF for indicated times and lysed
for western blotting. pJNK and total JNK levels were normalized
against 0 min GM-CSF (10 pM) sample. Total JNK was used as
loading control and shown are 54 kDa pJNK and total JNK. *
indicates p < 0.05 and ** p < 0.01 as compared with eosinophils
stimulated with GM-CSF and penicillamine for the corresponding
time, n = 7. Untreated cells were compared to 0 min GM-CSF
sample, n = 5. In B, eosinophils were preincubated with bongkrekic
acid for 2 h before adding SNAP, penicillamine and/or GM-CSF.
Incubation was continued for 2 h before cell lysis and western
blotting. Shown are mean ± SEM of 6 individual experiments. In C,
time-points shown below the columns refer to the addition times of
solvent, SP600125 (10 μM) or its negative control (10 μM). Time zero
represents the time of adding GM-CSF (10 pM) and SNAP (1 mM) or
penicillamine (1 mM). Total incubation time was 40 h and DNA
fragmentation assay was used for determination of apoptosis. Values
are mean ± SEM of 5 individual experiments. * indicates p < 0.05
and ** p < 0.01 versus respective control.
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flashes by knockdown or overexpression of mPT com-
ponent cyclophilin D decreased or increased selenite-
induced apoptosis, respectively [31]. However, this ma-
nipulation also affects the irreversible mPT and there is
no conclusive evidence that flickering mPT and the
associated superoxide flashes are necessary for apop-
tosis. Nevertheless, because treatment with NO ends up
in mPT-mediated apoptosis it is likely that flickering
mPT is an important point where anti-apoptotic and
pro-apoptotic signals converge and fate of the cell is
determined. Most probably, if a certain threshold is
achieved flickering mPT is turned into permanent mPT
and cell undergoes apoptosis or necrosis.
We showed that the early partial mPT led to strong
activation of JNK at 2 h. A smaller activation of JNK was
observed at later time-points (20–30 h). Consistently, a
previous study showed that apoptosis-inducing N-me-
thyl-4-phenylpyridinium (MPP+) induced early and late
phases of JNK activation in a mammalian cell line and
the early phase was preventable by bongkrekic acid [36].
They also found that the late JNK activation was inde-
pendent of mPT, which remains unsolved in our study.
However, in contrast to our study, Casarino et al. did
not show whether the early mPT-dependent JNK activa-
tion or late phase of JNK activation are relevant for
MPP+ −induced apoptosis. To our knowledge, this is the
first study to demonstrate mPT-mediated JNK activation
not related to apoptosis. According to our study, one
physiological function of flickering mPT may, therefore,
be initiation of JNK signalling in response to oxidative
stress probably aiming to cell rescue. Plenty of evidence
from studies conducted by others supports the conclusion
that the early mPT and the following JNK activation are a
Figure 5 Early ROS-production is involved in SNAP-induced apoptosis. Eosinophils were incubated with AEOL for 15 min (A), DPI (C) or
apocynin (D) for 20 min prior to stimulation with SNAP, penicillamine and/or GM-CSF for 40 hours. In B, AEOL was added 30 min prior to or 16 h
after SNAP and GM-CSF. Apoptosis was measured by DNA fragmentation assay. * indicates p < 0.05 and ** p < 0.01 versus respective control.
Shown are results from five to seven independent experiments.
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strated that rapid, strong and transient JNK activation is
a stress response resulting in cell survival signalling
while delayed and sustained JNK activation is related to
apoptosis [23,24]. Second, flickering mPT was shown to
be involved in cell protection during minor stress [34].
Additionally, Beltran et al. have demonstrated that long
exposure to NO by DETA-NONOate initially stimulates
a protective response by inhibiting complex IV in the
mitochondrial respiratory chain. This led to maintenance
of ΔΨm by hydrolysis of glycolytic ATP instead of the re-
spiratory chain and increased cell viability. The protective
response induced by NO turned into apoptotic response
by an unknown mechanism that was speculated to involve
accumulation of oxidative damage [37]. In eosinophils
ΔΨm is maintained exceptionally by hydrolysis of glyco-
lytic ATP rather than respiratory chain in contrast to most
eukaryotic cells [38] indicating that this mechanism is
already functional in eosinophils. Evidence of the survival-
increasing potential of NO in eosinophils has been shown
by several groups [39-41]. Hebestreit and co-workers
showed that NO stimulates eosinophil survival in the
presence of apoptosis-inducing Fas at 24 h time-point
[39]. Further time-points were not studied to see whether
the survival signalling would have turned into apoptoticsignalling. In our experiments GM-CSF produced max-
imal survival of eosinophils at 10 pM concentration mak-
ing it impossible to show that NO activates survival
machinery in eosinophils at early time-points. This evi-
dence supports the conclusion that NO-induced early
mPT and the following JNK activation are a protective re-
sponse of the cell.
ROS/RNS are known inducers of JNK in eosinophils
[42], which suggests that ROS formation may be
involved in the early mPT-dependent activation of
JNK. Studies by Zorov et al. [43] have shown a relation-
ship between ROS and mPT which raises an interesting
possibility for the mechanism of mPT-induced JNK acti-
vation. They showed that mitochondrial ROS accumula-
tion leads to mPT, which was followed by mitochondrial
ROS burst that can be released to the cytosol [43]. Also
Ma et al. demonstrated mPT-dependent superoxide
flashes in response to oxidative stress [31]. However,
whether this mechanism explains mPT-mediated early
JNK activation in NO-treated eosinophils remains to be
clarified.
Stimulation of GM-CSF-treated eosinophils with NO
resulted in permanent loss of ΔΨm and apoptosis at
40 h. Lost ΔΨm is often, but not always, a consequence
of permanent mPT [44]. Prevention of NO-mediated
Figure 6 A proposed model of the action of NO in GM-CSF-
treated eosinophils. As early events (1–2 hours), NO induces
flickering mPT that leads to JNK activation but these events are not
related to apoptosis and may act as an early protective response.
Later, the flickering mPT turns into sustained mPT, mitochondrial
membrane potential (ΔΨm) collapses and cell undergoes apoptosis.
A new phase of JNK activation occurs before late loss of
mitochondrial function and is involved in mediating apoptosis but
not via inducing disruption of mitochondrial function.
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gives further evidence that the threshold for permanent
mPT is crossed at time-point beyond 16 h. Previously,
NO was shown to induce permanent mPT in isolated
mitochondria and thymocytes [15]. In eosinophils, mPT
mediated dexamethasone-induced apoptosis [17].
JNK has been previously reported to mediate spontan-
eous apoptosis and apoptosis induced by several drugs
and nitric oxide in eosinophils [11,42,45]. In concord-
ance with our previous results, we found here that NO
activates JNK and JNK has a role in NO-induced apop-
tosis [11]. Similarly to the results with JNK peptide in-
hibitor 1 (L-JNKI1) in the previous study [11], two
additions of JNK inhibitor SP600125 (at 30 min before
and 16 h after SNAP) was required to suppress the pro-
apoptotic effect of NO. Either addition alone had no sta-
tistically significant effect on SNAP-induced apoptosis.
The result implies that the later phase of JNK activation
is required for apoptosis but the later phase may initiate
before 16 h. This is possible because we did not study
pJNK levels in time-points between 2 h and 20 h. With
the limited amounts of cells available for these studies
and the sensitivity of the current assays, it was not pos-
sible to determine the exact time, when the later phase
of JNK activation was initiated. The result also suggests
that the initial 10 μM concentration of SP600125 was
not adequate to inhibit JNK during long time-scale of
activation in contrast to 1 μM concentration of JNK in-
hibitor VIII that slightly but statistically significantly
suppressed the pro-apoptotic effect of SNAP. The mech-
anism by which JNK participates in NO-induced eosino-
phil apoptosis remains unclear. In previous studies with
other cell types and stimulants JNK has promoted apop-
tosis by inducing mPT [25,26]. However, this seems not
to be the mechanism in NO-induced apoptosis in eosi-
nophils since inhibition of JNK had no effect on the
SNAP-induced loss of ΔΨm. It is also possible that JNK
has a pro-apoptotic mechanism that is independent on
mPT. For example, JNK-mediated transcription has been
shown to enhance expression of Fas-ligand [46] indicat-
ing that JNK activation may stimulate extrinsic Fas path-
way of apoptosis in parallel to intrinsic mitochondrial
pathway. Alternatively, JNK-dependent mechanisms may
mediate the pathway from mPT to DNA fragmentation.
Under normal physiological condition, few per cent of
the oxygen consumed by mitochondria is converted to
superoxide. Cellular stress often leads to further increase
in superoxide production. Inhibition of the components
of the mitochondrial respiratory chain has been demon-
strated as one mechanism by which NO increases super-
oxide production [47]. Reaction between nitric oxide
and superoxide leads to formation of peroxynitrite. By
using SOD mimetic AEOL 10150, we showed that the
pro-apoptotic effect of SNAP on eosinophils in thepresence of GM-CSF is partly dependent on superoxide
and/or peroxynitrite production. However, addition of
SOD mimetic at 16 h time-point was no longer effective
in reversing the pro-apoptotic effect of SNAP suggesting
that early formation of superoxide and/or peroxynitrite
is critical for SNAP-induced apoptosis. Early NO-
induced ROS-production is in concordance with the
results of other studies [48,49]. Previously in other cell
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demonstrated to occur before caspase activation and the
following apoptosis [49,50]. However, the importance of
this early ROS peak for apoptosis has been unclear. Our
study shows that early increase of ROS is a critical event
mediating NO-induced eosinophil apoptosis. NO-
induced apoptosis seems to be initiated relatively late
suggesting importance of accumulation of oxidative
damage. Interestingly, because both apoptosis-related
formation of ROS and activation of JNK seem to initiate
before 16 h and ROS/RNS are known inducers of JNK
[42], ROS may also participate in activating the later
apoptosis-related JNK. Inhibition of apoptosis by AEOL
was only partial suggesting that NO-induced formation
of ROS is not the only key event for initiation of apop-
tosis. NO may also have direct apoptosis-stimulating
effects on eosinophils. Another possibility that may ex-
plain the result is inefficiency of the used SOD-mimetic
in dismutating all superoxide and peroxynitrite produc-
tion. According to our results with inhibitors of NADPH
oxidase, this enzyme is not the major source of super-
oxide in NO-treated eosinophils. This leaves mitochon-
drial electron transport chain as the most likely source
of superoxide.
Nitric oxide is abundant in the lungs of asthmatics and
thereby most likely affects eosinophil functions in a
physiological situation. In this study, in addition to the
mechanism of NO-induced apoptosis, we showed some
interesting early events in NO-stimulated eosinophils
that may take place even if the threshold for irreversible
mPT and apoptosis is not crossed. In fact, levels of NO in
the exhaled air has been shown to correlate to eosino-
philic inflammation [8,9] which makes it tempting to
speculate that NO might only induce flickering mPT and
JNK activation ending up in a protective response but
not apoptosis in a physiological situation.
Conclusions
We showed here that NO induces apoptosis of GM-
CSF-treated human eosinophils by a mechanism that
involves early oxidative stress, JNK activation and late
mPT. However, before irreversible activation of apop-
totic machinery NO induces early flickering mPT that
leads to JNK activation but is not related to apoptosis
(Figure 6). Thereby, we showed some interesting early
events in NO-stimulated eosinophils that may take place
even if the threshold for irreversible mPT and apoptosis
is not crossed. This study also revealed a previously un-
known physiological function for transient mPT by
showing that it may act as an initiator of non-apoptotic
cell signal transduction by activating JNK.
Competing interests
The authors declare that they have no competing interests.Authors’ contributions
PI-S participated in the study design, carried out experiments, performed
data analysis and wrote the manuscript. EM participated in conceiving of the
study and the study design and revised the manuscript critically for
important intellectual content. VLK revised the manuscript critically for
important intellectual content. HK conceived the study, participated in the
study design, data analysis and contributed to the writing of the manuscript.
All authors read and approved the final manuscript.
Acknowledgements
We thank Prof. James Crapo for providing AEOL 10150, Mrs. Elina Jaakkola
and Mrs. Marika Isokangas for technical assistance and Mrs. Heli Määttä for
secretary help. This work was supported by the Finnish Anti-Tuberculosis
Association Foundation (Helsinki, Finland), Tampere Tuberculosis Foundation
(Tampere, Finland), the Competitive Research Funding of Tampere University
Hospital (Grants 9H031, 9K048, 9N023 and 9G114; Tampere, Finland), the
Medical Research Fund of Seinäjoki Central Hospital (Seinäjoki, Finland),
Jalmari and Rauha Ahokas Foundation (Helsinki, Finland) and Allergy
Research Foundation (Helsinki, Finland).
Author details
1The Immunopharmacology Research Group, University of Tampere School
of Medicine and Tampere University Hospital, Tampere, Finland. 2Department
of Medicine, Division of Pulmonary Medicine, University of Helsinki and
Helsinki University Central Hospital, Helsinki, Finland. 3Department of
Respiratory Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland.
Received: 1 June 2012 Accepted: 20 August 2012
Published: 24 August 2012
References
1. Wenzel SE: Eosinophils in asthma–closing the loop or opening the door?
N Engl J Med 2009, 360:1026–1028.
2. Akuthota P, Wang HB, Spencer LA, Weller PF: Immunoregulatory roles of
eosinophils: A new look at a familiar cell. Clin Exp Allergy 2008,
38:1254–1263.
3. Humbles AA, Lloyd CM, McMillan SJ, Friend DS, Xanthou G, McKenna EE,
Ghiran S, Gerard NP, Yu C, Orkin SH, Gerard C: A critical role for eosinophils
in allergic airways remodeling. Science 2004, 305:1776–1779.
4. Kankaanranta H, Lindsay MA, Giembycz MA, Zhang X, Moilanen E, Barnes PJ:
Delayed eosinophil apoptosis in asthma. J Allergy Clin Immun 2000,
106:77–83.
5. Virchow JC Jr, Walker C, Hafner D, Kortsik C, Werner P, Matthys H, Kroegel C:
T cells and cytokines in bronchoalveolar lavage fluid after segmental
allergen provocation in atopic asthma. Am J Respir Crit Care Med 1995,
151:960–968.
6. Park CS, Choi YS, Ki SY, Moon SH, Jeong SW, Uh ST, Kim YH: Granulocyte
macrophage colony-stimulating factor is the main cytokine enhancing
survival of eosinophils in asthmatic airways. Eur Respir J 1998, 12:872–878.
7. Korhonen R, Lahti A, Kankaanranta H, Moilanen E: Nitric oxide production
and signaling in inflammation. Curr Drug Targets Inflamm Allergy 2005,
4:471–479.
8. Lehtimaki L, Kankaanranta H, Saarelainen S, Hahtola P, Jarvenpaa R, Koivula
T, Turjanmaa V, Moilanen E: Extended exhaled NO measurement
differentiates between alveolar and bronchial inflammation. Am J Respir
Crit Care Med 2001, 163:1557–1561.
9. Payne DN, Adcock IM, Wilson NM, Oates T, Scallan M, Bush A: Relationship
between exhaled nitric oxide and mucosal eosinophilic inflammation in
children with difficult asthma, after treatment with oral prednisolone.
Am J Respir Crit Care Med 2001, 164:1376–1381.
10. Oliveira MS, de O Barreto E, Zamuner S, Pires AL, Ferreira TP, Cordeiro RS,
Lagente V, Martins MA, Wallace JL, e Silva PM: Suppressive effects of nitric
oxide-releasing prednisolone NCX-1015 on the allergic pleural
eosinophil recruitment in rats. Clin Exp Allergy 2008, 38:1830–1837.
11. Zhang X, Moilanen E, Lahti A, Hamalainen M, Giembycz MA, Barnes PJ,
Lindsay MA, Kankaanranta H: Regulation of eosinophil apoptosis by nitric
oxide: Role of c-jun-N-terminal kinase and signal transducer and
activator of transcription 5. J Allergy Clin Immun 2003, 112:93–101.
12. Ilmarinen-Salo P, Moilanen E, Kankaanranta H: Nitric oxide induces
apoptosis in GM-CSF-treated eosinophils via caspase-6-dependent lamin
and DNA fragmentation. Pulm Pharmacol Ther 2010, 23:365–371.
Ilmarinen-Salo et al. Respiratory Research 2012, 13:73 Page 11 of 11
http://respiratory-research.com/content/13/1/7313. Pontin J, Blaylock MG, Walsh GM, Turner SW: Sputum eosinophil apoptotic
rate is positively correlated to exhaled nitric oxide in children.
Pediatr Pulmonol 2008, 43:1130–1134.
14. Brown GC, Borutaite V: Nitric oxide inhibition of mitochondrial respiration
and its role in cell death. Free Radic Biol Med 2002, 33:1440–1450.
15. Hortelano S, Dallaporta B, Zamzami N, Hirsch T, Susin SA, Marzo I, Bosca L,
Kroemer G: Nitric oxide induces apoptosis via triggering mitochondrial
permeability transition. FEBS Lett 1997, 410:373–377.
16. Kroemer G, Galluzzi L, Brenner C: Mitochondrial membrane
permeabilization in cell death. Physiol Rev 2007, 87:99–163.
17. Letuve S, Druilhe A, Grandsaigne M, Aubier M, Pretolani M: Critical role of
mitochondria, but not caspases, during glucocorticosteroid-induced
human eosinophil apoptosis. Am J Respir Cell Mol Biol 2002, 26:565–571.
18. Dhanasekaran DN, Reddy EP: JNK signaling in apoptosis. Oncogene 2008,
27:6245–6251.
19. Salvioli S, Ardizzoni A, Franceschi C, Cossarizza A: JC-1, but not DiOC6(3) or
rhodamine 123, is a reliable fluorescent probe to assess delta psi
changes in intact cells: Implications for studies on mitochondrial
functionality during apoptosis. FEBS Lett 1997, 411:77–82.
20. Petronilli V, Miotto G, Canton M, Brini M, Colonna R, Bernardi P, Di Lisa F:
Transient and long-lasting openings of the mitochondrial permeability
transition pore can be monitored directly in intact cells by changes in
mitochondrial calcein fluorescence. Biophys J 1999, 76:725–734.
21. Petronilli V, Penzo D, Scorrano L, Bernardi P, Di Lisa F: The mitochondrial
permeability transition, release of cytochrome c and cell death.
correlation with the duration of pore openings in situ. J Biol Chem 2001,
276:12030–12034.
22. Ichas F, Jouaville LS, Mazat JP: Mitochondria are excitable organelles
capable of generating and conveying electrical and calcium signals. Cell
1997, 89:1145–1153.
23. Ventura JJ, Hubner A, Zhang C, Flavell RA, Shokat KM, Davis RJ: Chemical
genetic analysis of the time course of signal transduction by JNK. Mol
Cell 2006, 21:701–710.
24. Sanchez-Perez I, Murguia JR, Perona R: Cisplatin induces a persistent
activation of JNK that is related to cell death. Oncogene 1998, 16:533–540.
25. Hanawa N, Shinohara M, Saberi B, Gaarde WA, Han D, Kaplowitz N: Role of
JNK translocation to mitochondria leading to inhibition of mitochondria
bioenergetics in acetaminophen-induced liver injury. J Biol Chem 2008,
283:13565–13577.
26. Lin X, Wang YJ, Li Q, Hou YY, Hong MH, Cao YL, Chi ZQ, Liu JG: Chronic
high-dose morphine treatment promotes SH-SY5Y cell apoptosis via
c-jun N-terminal kinase-mediated activation of mitochondria-dependent
pathway. FEBS J 2009, 276:2022–2036.
27. Kinnula VL, Crapo JD: Superoxide dismutases in the lung and human lung
diseases. Am J Respir Crit Care Med 2003, 167:1600–1619.
28. Halestrap AP, Brenner C: The adenine nucleotide translocase: A central
component of the mitochondrial permeability transition pore and key
player in cell death. Curr Med Chem 2003, 10:1507–1525.
29. Kokoszka JE, Waymire KG, Levy SE, Sligh JE, Cai J, Jones DP, MacGregor GR,
Wallace DC: The ADP/ATP translocator is not essential for the
mitochondrial permeability transition pore. Nature 2004, 427:461–465.
30. Vieira HL, Belzacq AS, Haouzi D, Bernassola F, Cohen I, Jacotot E, Ferri KF, El
Hamel C, Bartle LM, Melino G, Brenner C, Goldmacher V, Kroemer G: The
adenine nucleotide translocator: A target of nitric oxide, peroxynitrite,
and 4-hydroxynonenal. Oncogene 2001, 20:4305–4316.
31. Ma Q, Fang H, Shang W, Liu L, Xu Z, Ye T, Wang X, Zheng M, Chen Q,
Cheng H: Superoxide flashes: Early mitochondrial signals for oxidative
stress-induced apoptosis. J Biol Chem 2011, 286:27573–27581.
32. Bernardi P, Petronilli V: The permeability transition pore as a
mitochondrial calcium release channel: A critical appraisal. J Bioenerg
Biomembr 1996, 28:131–138.
33. Barsukova A, Komarov A, Hajnoczky G, Bernardi P, Bourdette D, Forte M:
Activation of the mitochondrial permeability transition pore modulates
Ca2+ responses to physiological stimuli in adult neurons. Eur J Neurosci
2011, 33:831–842.
34. Saotome M, Katoh H, Yaguchi Y, Tanaka T, Urushida T, Satoh H, Hayashi H:
Transient opening of mitochondrial permeability transition pore by
reactive oxygen species protects myocardium from ischemia-reperfusion
injury. Am J Physiol Heart Circ Physiol 2009, 296:H1125–H1132.
35. Balakirev MY, Khramtsov VV, Zimmer G: Modulation of the mitochondrial
permeability transition by nitric oxide. Eur J Biochem 1997, 246:710–718.36. Cassarino DS, Halvorsen EM, Swerdlow RH, Abramova NN, Parker WD Jr,
Sturgill TW, Bennett JP Jr: Interaction among mitochondria, mitogen-
activated protein kinases, and nuclear factor-kappaB in cellular models
of parkinson's disease. J Neurochem 2000, 74:1384–1392.
37. Beltran B, Mathur A, Duchen MR, Erusalimsky JD, Moncada S: The effect of
nitric oxide on cell respiration: A key to understanding its role in cell
survival or death. Proc Natl Acad Sci USA 2000, 97:14602–14607.
38. Peachman KK, Lyles DS, Bass DA: Mitochondria in eosinophils: Functional
role in apoptosis but not respiration. Proc Natl Acad Sci USA 2001,
98:1717–1722.
39. Hebestreit H, Dibbert B, Balatti I, Braun D, Schapowal A, Blaser K, Simon HU:
Disruption of fas receptor signaling by nitric oxide in eosinophils. J Exp
Med 1998, 187:415–425.
40. Beauvais F, Michel L, Dubertret L: The nitric oxide donors, azide and
hydroxylamine, inhibit the programmed cell death of cytokine-deprived
human eosinophils. FEBS Lett 1995, 361:229–232.
41. Beauvais F, Joly F: Effects of nitric oxide on the eosinophil survival
in vitro. A role for nitrosyl-heme. FEBS Lett 1999, 443:37–40.
42. Gardai SJ, Hoontrakoon R, Goddard CD, Day BJ, Chang LY, Henson PM,
Bratton DL: Oxidant-mediated mitochondrial injury in eosinophil
apoptosis: Enhancement by glucocorticoids and inhibition by
granulocyte-macrophage colony-stimulating factor. J Immunol 2003,
170:556–566.
43. Zorov DB, Juhaszova M, Sollott SJ: Mitochondrial ROS-induced ROS
release: An update and review. Biochim Biophys Acta 2006, 1757:509–517.
44. Green DR, Kroemer G: The pathophysiology of mitochondrial cell death.
Science 2004, 305:626–629.
45. Kankaanranta H, Ilmarinen P, Zhang X, Nissinen E, Moilanen E:
Antieosinophilic activity of orazipone. Mol Pharmacol 2006, 69:1861–1870.
46. Morishima Y, Gotoh Y, Zieg J, Barrett T, Takano H, Flavell R, Davis RJ,
Shirasaki Y, Greenberg ME: Beta-amyloid induces neuronal apoptosis via a
mechanism that involves the c-jun N-terminal kinase pathway and the
induction of fas ligand. J Neurosci 2001, 21:7551–7560.
47. Cleeter MW, Cooper JM, Darley-Usmar VM, Moncada S, Schapira AH:
Reversible inhibition of cytochrome c oxidase, the terminal enzyme of
the mitochondrial respiratory chain, by nitric oxide. implications for
neurodegenerative diseases. FEBS Lett 1994, 345:50–54.
48. Wei T, Chen C, Hou J, Xin W, Mori A: Nitric oxide induces oxidative stress
and apoptosis in neuronal cells. Biochim Biophys Acta 2000, 1498:72–79.
49. Machiavelli LI, Poliandri AH, Quinteros FA, Cabilla JP, Duvilanski BH: Reactive
oxygen species are key mediators of the nitric oxide apoptotic pathway
in anterior pituitary cells. Nitric Oxide 2007, 16:237–246.
50. Moriya R, Uehara T, Nomura Y: Mechanism of nitric oxide-induced
apoptosis in human neuroblastoma SH-SY5Y cells. FEBS Lett 2000,
484:253–260.
doi:10.1186/1465-9921-13-73
Cite this article as: Ilmarinen-Salo et al.: Nitric oxide-induced eosinophil
apoptosis is dependent on mitochondrial permeability transition (mPT),
JNK and oxidative stress: apoptosis is preceded but not mediated by
early mPT-dependent JNK activation. Respiratory Research 2012 13:73.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
